Haemonetics (HAE) News Today $71.15 -0.87 (-1.21%) (As of 10/31/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Haemonetics (HAE) Set to Announce Quarterly Earnings on ThursdayHaemonetics (NYSE:HAE) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633040)October 31 at 1:50 AM | marketbeat.comBoston Trust Walden Corp Purchases 98,019 Shares of Haemonetics Co. (NYSE:HAE)Boston Trust Walden Corp raised its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 13.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 809,608 shares of the medical instruments supplier's stock after acquiring anOctober 26, 2024 | marketbeat.comIntellia Therapeutics Advances with Promising Phase 2 ResultsOctober 25, 2024 | markets.businessinsider.comIntellia Therapeutics: Promising Phase 2 Results and Growth Potential Justify Buy RatingOctober 25, 2024 | markets.businessinsider.comIntellia slips after mid-stage data for CRISPR-based hereditary angioedema therapyOctober 24, 2024 | seekingalpha.comBioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)October 24, 2024 | finance.yahoo.comHaemonetics Co. (NYSE:HAE) Stock Position Boosted by Riverwater Partners LLCRiverwater Partners LLC raised its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 185.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,841 shares of the medical iOctober 24, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Grows Position in Haemonetics Co. (NYSE:HAE)Allspring Global Investments Holdings LLC boosted its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 75.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 795,381 shares of the medical instruments supplier's stockOctober 22, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Stock Quotes, Forecast and News SummaryOctober 13, 2024 | benzinga.comSG Americas Securities LLC Reduces Stock Position in Haemonetics Co. (NYSE:HAE)SG Americas Securities LLC decreased its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 48.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,832 shares of the medical instruments supplier's stock after sellingOctober 13, 2024 | marketbeat.comHaemonetics Corp (HAE) Q1 2025 Earnings Call Highlights: Navigating Growth and ChallengesOctober 9, 2024 | finance.yahoo.comA Glimpse of Neogen's Earnings PotentialOctober 9, 2024 | benzinga.comSquarepoint Ops LLC Sells 34,579 Shares of Haemonetics Co. (NYSE:HAE)Squarepoint Ops LLC decreased its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 80.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 8,318 shares of the medical instruments supplier's stock after selling 34,579 shares duringOctober 8, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC decreased its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 34.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 83,988 shares of the medical instruments suppOctober 4, 2024 | marketbeat.comHaemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024October 3, 2024 | prnewswire.comAlgert Global LLC Sells 30,945 Shares of Haemonetics Co. (NYSE:HAE)Algert Global LLC trimmed its position in Haemonetics Co. (NYSE:HAE - Free Report) by 57.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,972 shares of the medical instruments supplier's stock aftOctober 3, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Has $25.45 Million Stock Position in Haemonetics Co. (NYSE:HAE)The Manufacturers Life Insurance Company increased its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 327.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 307,564 shares of the medical instruments supplieOctober 2, 2024 | marketbeat.comCubist Systematic Strategies LLC Acquires Shares of 23,263 Haemonetics Co. (NYSE:HAE)Cubist Systematic Strategies LLC acquired a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 23,263 shares of the medical instruments supplieOctober 1, 2024 | marketbeat.comPoint72 Asset Management L.P. Boosts Position in Haemonetics Co. (NYSE:HAE)Point72 Asset Management L.P. grew its position in Haemonetics Co. (NYSE:HAE - Free Report) by 178.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 219,024 shares of the medical insSeptember 30, 2024 | marketbeat.com55,500 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Renaissance Technologies LLCRenaissance Technologies LLC bought a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 55,500 shares of the medical instruments supplier's stock, valued at approximatelySeptember 28, 2024 | marketbeat.comPoint72 Hong Kong Ltd Purchases Shares of 11,592 Haemonetics Co. (NYSE:HAE)Point72 Hong Kong Ltd purchased a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,592 shares of the medical instruments supplier's stock, valued at approSeptember 26, 2024 | marketbeat.comIntech Investment Management LLC Makes New $1.13 Million Investment in Haemonetics Co. (NYSE:HAE)Intech Investment Management LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 13,703 shares of the medical instruments supplier'September 25, 2024 | marketbeat.comBuy Rating Affirmed for Haemonetics with Promising Growth in Hospital Segment and Strong Plasma Market PositionSeptember 24, 2024 | markets.businessinsider.comTaking A Look At Haemonetics Corporation's (NYSE:HAE) ROESeptember 24, 2024 | finance.yahoo.comHaemonetics (NYSE:HAE) Receives "Outperform" Rating from Barrington ResearchBarrington Research reissued an "outperform" rating and issued a $108.00 target price on shares of Haemonetics in a report on Monday.September 23, 2024 | marketbeat.comHood River Capital Management LLC Has $20.28 Million Stock Position in Haemonetics Co. (NYSE:HAE)Hood River Capital Management LLC increased its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 880.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 245,090 shares of the medical instruments supplier's stoSeptember 23, 2024 | marketbeat.comThrivent Financial for Lutherans Grows Position in Haemonetics Co. (NYSE:HAE)Thrivent Financial for Lutherans raised its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 6,573.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 849,350 shares of the medical instruments supplier's stock after acquiring an additSeptember 22, 2024 | marketbeat.comHaemonetics Technology Chief to ExitSeptember 16, 2024 | marketwatch.comFY2027 Earnings Forecast for Haemonetics Co. Issued By Zacks Research (NYSE:HAE)Haemonetics Co. (NYSE:HAE - Free Report) - Stock analysts at Zacks Research lifted their FY2027 EPS estimates for shares of Haemonetics in a report issued on Thursday, September 12th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings of $5.9September 16, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Short Interest Up 20.6% in AugustHaemonetics Co. (NYSE:HAE - Get Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 6,090,000 shares, an increase of 20.6% from the August 15th total of 5,050,000 shares. Currently, 12.0% of the company's stock are short sold. Based on an average daily volume of 582,100 shares, the days-to-cover ratio is currently 10.5 days.September 15, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by Cornercap Investment Counsel Inc.Cornercap Investment Counsel Inc. lowered its position in Haemonetics Co. (NYSE:HAE - Free Report) by 61.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,985 shares of the medical instruments supplier's stock afteSeptember 15, 2024 | marketbeat.comCL King Initiates Coverage of Haemonetics (HAE) with Buy RecommendationSeptember 14, 2024 | nasdaq.comTexas Permanent School Fund Corp Has $4.28 Million Position in Haemonetics Co. (NYSE:HAE)Texas Permanent School Fund Corp boosted its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 16.3% in the second quarter, according to its most recent filing with the SEC. The firm owned 51,714 shares of the medical instruments supplier's stock after acquiring an additional 7,267September 14, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Coverage Initiated by Analysts at CL KingCL King began coverage on shares of Haemonetics in a report on Friday. They set a "buy" rating and a $116.00 target price on the stock.September 13, 2024 | marketbeat.comHaemonetics Co. Expected to Post FY2025 Earnings of $4.56 Per Share (NYSE:HAE)Haemonetics Co. (NYSE:HAE - Free Report) - Research analysts at Zacks Research raised their FY2025 EPS estimates for Haemonetics in a research note issued on Thursday, September 12th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earnings perSeptember 13, 2024 | marketbeat.comTD Asset Management Inc Has $2.62 Million Stake in Haemonetics Co. (NYSE:HAE)TD Asset Management Inc reduced its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 39.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,646 shares of the medical instruments supplier's stocSeptember 13, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been given an average recommendation of "Moderate Buy" by the six analysts that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendaSeptember 12, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Acquired by Victory Capital Management Inc.Victory Capital Management Inc. lifted its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 45.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 277,169 shares of the medical instrumeSeptember 12, 2024 | marketbeat.comB of A Securities Initiates Coverage of Haemonetics (HAE) with Neutral RecommendationSeptember 12, 2024 | msn.comHaemonetics (NYSE:HAE) Now Covered by Bank of AmericaBank of America began coverage on shares of Haemonetics in a research report on Wednesday. They set a "neutral" rating and a $85.00 price target on the stock.September 11, 2024 | marketbeat.comBTIG Initiates Coverage of Haemonetics (HAE) with Buy RecommendationSeptember 10, 2024 | msn.comHaemonetics: A Solid Investment in MedTech with Promising Growth and Valuation UpsideSeptember 10, 2024 | markets.businessinsider.comWhat Analysts Are Saying About Haemonetics StockSeptember 10, 2024 | benzinga.comHaemonetics (NYSE:HAE) Earns Buy Rating from Analysts at BTIG ResearchBTIG Research assumed coverage on shares of Haemonetics in a report on Tuesday. They issued a "buy" rating and a $112.00 price objective for the company.September 10, 2024 | marketbeat.comEmerald Advisers LLC Has $5.47 Million Holdings in Haemonetics Co. (NYSE:HAE)Emerald Advisers LLC reduced its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 49.3% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 66,108 shares of the medical instruments supplier's stock after selling 64,329 shares duriSeptember 9, 2024 | marketbeat.comGreat Lakes Advisors LLC Has $13.18 Million Stake in Haemonetics Co. (NYSE:HAE)Great Lakes Advisors LLC lowered its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 4.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 159,340 shares of the medical instruments supplier's stock after selling 8,September 8, 2024 | marketbeat.comWolverine Asset Management LLC Purchases Shares of 17,250 Haemonetics Co. (NYSE:HAE)Wolverine Asset Management LLC acquired a new position in Haemonetics Co. (NYSE:HAE - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The firm acquired 17,250 shares of the medical instruments supplier's stock, valued at approximately $1,427,000. OtherSeptember 5, 2024 | marketbeat.comEquities Analysts Set Expectations for Haemonetics Co.'s Q3 2025 Earnings (NYSE:HAE)Haemonetics Co. (NYSE:HAE - Free Report) - Equities researchers at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for shares of Haemonetics in a research report issued on Wednesday, August 28th. Zacks Research analyst R. Department now expects that the medical instrumentsSeptember 2, 2024 | marketbeat.comMizuho Markets Americas LLC Takes $30.08 Million Position in Haemonetics Co. (NYSE:HAE)Mizuho Markets Americas LLC acquired a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 363,594 shares of the medical instruments supplier's stock, valued at approximately $30,080,000. Haemonetics makesAugust 31, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Has $37.41 Million Stake in Haemonetics Co. (NYSE:HAE)Allspring Global Investments Holdings LLC lowered its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 10.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 452,167 shares of the medical instruments supplier's stock after sAugust 27, 2024 | marketbeat.com Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)The recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull run is over. But if history has taught us anything, it’s that this is only the beginning. >> Dive into the Workshop Here HAE Media Mentions By Week HAE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼0.800.68▲Average Medical News Sentiment HAE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼55▲HAE Articles Average Week Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Merit Medical Systems News DENTSPLY SIRONA News ICU Medical News Neogen News QuidelOrtho News STAAR Surgical News Anika Therapeutics News Cerus News OraSure Technologies News Utah Medical Products News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.